Green fluorescent protein fusions with random peptides

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6596485
APP PUB NO 20010003650A1
SERIAL NO

09749959

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the use of fluorescent proteins, particularly green fluorescent protein (GFP), in fusion constructs with random and defined peptides and peptide libraries, to increase the cellular expression levels, decrease the cellular catabolism, increase the conformational stability relative to linear peptides, and to increase the steady state concentrations of the random peptides and random peptide library members expressed in cells for the purpose of detecting the presence of the peptides and screening random peptide libraries. N-terminal, C-terminal, dual N- and C-terminal and one or more internal fusions are all contemplated. Novel fusions utilizing self-binding peptides to create a conformationally stabilized fusion domain are also contemplated.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • RIGEL PHARMACEUTICALS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Anderson, David San Bruno, CA 372 10922
Bogenberger, Jakob Maria Menlo Park, CA 7 130

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation